Ultra High Dose Rate Radiation: An overview of the advantages and applications beyond the FLASH effect.
22/11/2023
/
Webinar
In the weeks following the Flash Radiation Therapy conference FRPT in Toronto, IBA Proton Therapy invites you to hear about and discuss the additional benefits...
Delivery of re-irradiation and complex palliative radiotherapy using proton therapy in pediatric cancer patients.
23/11/2023
/
Publications
This study from Upenn retrospectively reviewed 18 pediatric patients who received palliative-intent proton radiation therapy (PIPRT), and reported that the most...
Clinical Insight on Proton Therapy for Paediatric Rhabdomyosarcoma.
23/11/2023
/
Publications
This review article provides a comprehensive analysis of the literature focusing on assessment of comparative photon-proton dosimetry, oncological outcome and...
Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patients.
23/11/2023
/
Publications
This study by the MGH group reported outcomes of 204 pediatric patients with chordomas treated by surgery and proton radiotherapy (PRT). Forty-seven patients...
Cochlear-optimized treatment planning in photon and proton radiosurgery for vestibular schwannoma patients.
23/11/2023
/
Publications
This study compared photon radiosurgery plans and IMPT plans to the clinically delivered photon treatment plans of 24 vestibular schwannoma patients to...
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature.
23/11/2023
/
Publications
This systematic review summarized results of the literature in the setting of patients treated with hypofractionated PT for benign lesions of the central...
New developments in PT: Motion Management, DynamicARC® and ConformalFLASH®
26/05/2021
/
Webinar
/
FLASH Therapy
ARC therapy
Motion Management
Watch our session from the virtual NAPT 2021 conference with Dr. Alonso Gutierrez and Swati Ghandi presenting topics related to ConformalFLASH®, DynamicARC® and...
Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
23/11/2023
/
Publications
This study reported outcomes of 31 recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) patients treated with combined proton therapy and...
Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers.
23/11/2023
/
Publications
This study reviewed 483 patients with various types of head and neck cancer (HNC), and reported that the nasopharyngeal carcinoma (NPC) patients had a higher...
Prospective Feasibility and Phase 1/2 Trial of Preoperative Proton Beam Therapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung Cancer.
23/11/2023
/
Publications
Published in the Red Journal, this is a brief report detailing a novel prospective feasibility and phase1/2 dose-scalation study of PBT as part of trimodality...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.